Page 446«..1020..445446447448..460470..»

SANA BIOTECHNOLOGY, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) – Marketscreener.com

Posted: May 15, 2022 at 1:55 am

You should read the following discussion and analysis of our financial conditionand results of operations together with our unaudited condensed consolidatedfinancial statements and the related notes included elsewhere in this QuarterlyReport and our audited consolidated financial statements and notes thereto andthe related Management's Discussion and Analysis of Financial Condition andResults of Operations included as part of our Annual Report on Form 10-K asfiled with the SEC on March 16, 2022 (2021 Annual Report). This discussion andanalysis and other parts of this Quarterly Report contain forward-lookingstatements that are based upon current beliefs, plans and expectations relatedto future events and our future financial performance that involve risks,uncertainties, and assumptions, such as statements regarding our intentions,plans, objectives, and expectations for our business. Our actual results and thetiming of selected events could differ materially from those described in orimplied by these forward-looking statements as a result of numerous factors,including those set forth in the section titled "Risk Factors." See also thesection titled "Special Note Regarding Forward-Looking Statements."

Overview

range of therapeutic areas. We are in the early stages of development across abroad pipeline of product candidates, all of which are currently in thepreclinical stage of development and are summarized below:

COVID-19 business update

Acquisitions

License and collaboration agreements

Success payments and contingent consideration

Cobalt success payment and contingent consideration

Components of operating results

Operating expenses

Research and development

Research and development related success payments and contingent consideration

General and administrative

Results of operations

Comparison of the three months ended March 31, 2022 and 2021

Research and development expenses

The following table summarizes the components of our research and developmentexpenses for the periods presented:

$ 41,880 $ 30,809

an increase of $11.2 million in personnel-related expenses, including an

increase in non-cash stock-based compensation of $3.0 million, which was

an increase of $9.1 million in research, development, and laboratory

costs, including third-party manufacturing costs, laboratory supplies, and

other external research expenses;

an increase of $5.3 million in facility and allocated costs, including

an increase of $4.9 million related to licensing technology for our CD22

and BCMA programs.

Research and development related success payments and contingent consideration

$ 127,050 $ (182,488 )

General and administrative Expenses

Liquidity, capital resources, and capital requirements

Sources of liquidity

Future funding requirements

Our future capital requirements will depend on many factors, including:

the scope, timing, progress, costs, and results of discovery, preclinical

the number and scope of clinical trials required for regulatory approval

of our current or future product candidates;

the costs, timing, and outcome of regulatory review of our current or

future product candidates;

the cost associated with building our manufacturing capabilities, as well

as costs associated with the manufacturing of clinical and commercial

supplies of our current and future product candidates;

the costs and timing of future commercialization activities, including

manufacturing, marketing, sales, and distribution, for any of our product

applications, maintaining and enforcing our intellectual property rights,

and defending any intellectual property-related claims, including any

claims by third parties that we are infringing upon their intellectual

collaborations, licensing, or other arrangements and the financial terms

of any such agreements, including the timing and amount of any future

milestone, royalty, or other payments due under any such agreement;

the revenue, if any, received from commercial sales of our product

our ability to establish a commercially viable pricing structure and

obtain approval for coverage and adequate reimbursement from third-party

and government payors;

potential interruptions or delays resulting from factors related to the

the extent to which we acquire or invest in businesses, products, and

technologies.

Cash flows

The following table summarizes our cash flows for the periods indicated:

Financing activities

Contractual obligations and commitments

The following table summarizes our significant contractual obligations andcommitments as of March 31, 2022:

Off-balance sheet arrangements

Since our inception, we have not engaged in any off-balance sheet arrangementsas defined under the rules and regulations of the SEC.

JOBS Act accounting election

Critical accounting policies and significant judgements and estimates

--------------------------------------------------------------------------------

Edgar Online, source Glimpses

Originally posted here:
SANA BIOTECHNOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.com

Posted in Biotechnology | Comments Off on SANA BIOTECHNOLOGY, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) – Marketscreener.com

Nanomedicine Market to 2030 Insights and Forecast with Impact of COVID-19 | Abbott Laboratories, DiaSorin S.p.A, Invitae Corporation, Mallinckrodt…

Posted: May 2, 2022 at 2:50 am

Nanomedicine Market Overview

The nanomedicine market has been predicted to grow at a noticeable pace in the forthcoming years. The growth opportunities in the global market are attributed to the emerging innovative technologies for the delivery of the drug. In addition to this, advantages related to nanomedicine in different healthcare applications along with growth in the requirement for cost-effective and safe therapies. Thus, based on these factors, the global market has been predicted to drive growth opportunities in the global market during the forecast period.

Get Exclusive PDF Sample Copy Of This Report: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=7961

Nanomedicine is a branch of medicine that commonly applies the knowledge of nanotechnology to prevent and treat diseases. Further, nanomedicine involves the use of nanoscale materials, for instance, nanorobots and biocompatible nanoparticles to diagnose, deliver, sense, or for actuation purposes in the living organism.

Nanomedicine Market Key Drivers

Rising R & D activities related to nanorobots and noteworthy investments in the clinical trials by private as well as government sectors are projected to contribute to the growth impetuses in the nanomedicine market in the near future.

Nanomaterials generally possess novel physicochemical properties that vary from the traditional bulk chemical equivalents because of their smaller size. Further, these properties increase the set of opportunities in the development of drugs. These properties of nanoformulation can lead to alteration of pharmacokinetics, for instance, metabolism, elimination, distribution, and absorption. These properties have the potential to cross biological barriers and toxic properties. They are persistent in the human body and environment. Thus, on the basis of these advanced features, the nanomedicine market has been estimated to expand at a noteworthy speed in the following years.

On the flip side, the risk associated with nanomedicines, especially environmental impact and long approval process is estimated to restrict the growth prospects in the global market. Growth of the healthcare facilities and increasing out-licensing of the nano drugs are estimated to provide novel growth avenues in the global market in the following years.

Buy This Report @ https://www.tmrresearch.com/checkout?rep_id=7961&ltype=S

Nanomedicine Market Recent Developments and Key Players

The nanomedicine market is fragmented in nature. The market is further characterized by the presence of certain regional and international players. In addition to this, the market players are focusing on various strategies for the achievement of their desired profits, the development of brand awareness, and penetration in the developing markets. Furthermore, these market players concentrate on the enhancement of their services in order to gain a large consumer base. Novel product launches, agreements or partnerships, expansion of company networks, and mergers and acquisitions are certain factors that are estimated to drive the growth opportunities in the global market during the forecast period.

Some of the key players in the nanomedicine market are:

Nanomedicine Market Regional Assessment

The nanomedicine market has been divided into four major regional areas that include North America, Europe, Asia Pacific, and LAMEA. North America is predicted to hold a noteworthy share in the global market because of the increasing number of lethal diseases. In addition to this, availability of the advanced healthcare facilities and surging demand for nanomedicines are also estimated to create sales avenues in the regional market in the near future. In addition to this, the availability of trained healthcare professionals, the presence of larger market players, increased investments that are made by government bodies in the healthcare system, and the growing number of R & D activities are some other pivotal factors that are likely to stimulate the expansion opportunities in the nanomedicine market in the following years.

To know more about the table of contents, you can click @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=7961

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to busi-ness entities keen on succeeding in todays supercharged economic climate. Armed with an experi-enced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Read the original post:
Nanomedicine Market to 2030 Insights and Forecast with Impact of COVID-19 | Abbott Laboratories, DiaSorin S.p.A, Invitae Corporation, Mallinckrodt...

Posted in Nano medicine | Comments Off on Nanomedicine Market to 2030 Insights and Forecast with Impact of COVID-19 | Abbott Laboratories, DiaSorin S.p.A, Invitae Corporation, Mallinckrodt…

Nano state: tiny and now everywhere, how big a problem are nanoparticles? – The Guardian

Posted: May 2, 2022 at 2:50 am

In 2019, Ikea announced it had developed curtains that it claimed could break down common indoor air pollutants. The secret, it said, was the fabrics special coating. What if we could use textiles to clean the air? asked Ikeas product developer, Mauricio Affonso, in a promotional video for the Gunrid curtains.

After explaining that the coating was a photocatalyst (similar to photosynthesis, found in nature), Affonso is shown gazing up at the gauzy curtains while uplifting music plays. Its amazing to work on something that can give people the opportunity to live a healthier life at home.

Puzzled by these claims how could a mineral coating clean the air? Avicenn, a French environmental nonprofit organisation, investigated. Independent laboratory tests of the Gunrid textile reported that samples contained tiny particles of titanium dioxide (TiO2) a substance not normally toxic but which can be possibly carcinogenic if inhaled, and potentially in other forms which supposedly gives self-cleaning properties to things such as paint and windows when exposed to sunlight.

These tiny particles, or nanoparticles, are at the forefront of materials science. Nanoparticles come in all shapes spheres, cubes, fibres or sheets but the crucial thing is their size: they are smaller than 100 nanometres (a human hair is approximately 80,000nm thick).

Many nanoparticles exist in nature. Nano-hairs make a geckos feet sticky, and nano-proteins make a spiders silk strong. But they can be manufactured, and because they are so small, they have special properties that make them attractive across a range of endeavours not just to companies such as Ikea. In medicine, they can transport cancer drugs directly into tumour cells, and nanosilver is used to coat medical breathing tubes and bandages. Nanos could direct pesticides to parts of a plant, or release nutrients from fertilisers in a more controlled manner.

They also have more mundane uses. Synthetic nanos are added to cosmetics and food. Nanosilver is used in textiles, where it is claimed to give antibacterial properties to plasters, gym leggings, yoga mats and period pants.

But scientists such as those at Avicenn are concerned that when these household items get washed, recycled or thrown away, synthetic nanos are released into the environment making their way into the soil and sea in ways that are still not understood. Some scientists believe nanoparticles could pose an even greater threat than microplastics.

Synthetic nano particles of plastic have been found in the ocean and in ice on both poles. Nanoparticles from socks and sunscreen have been found to pollute water, and certain nanos have been shown to negatively affect marine wildlife including fish and crustaceans. As with antibiotics, resistance to antimicrobial nanosilver can develop silver-tolerant soil bacteria have now been found.

Little is known even about where nanoparticles are, let alone their effects on the environment. As they are so tiny, most experiments are conducted in labs, and it can be hard to pin down where they are applied.

The main problem with these substances is that we cannot measure them we know they are there but theyre so tiny theyre difficult to detect, which is why you dont hear as much about them, says Nick Voulvoulis, professor of environmental technology at Imperial College London.

He worries about the uncontrolled use of nanos in consumer products. If nanos are used properly in applications that are useful or beneficial, thats justified, but if they are used anywhere and everywhere because they have certain properties, thats crazy.

Synthetic nanoparticles are not inherently harmful. Like their natural cousins, many are metal-based, but they can be made of any substance. Crucially, unlike chemical compounds, they cannot be dissolved. Their tiny size gives them, paradoxically, an enormous surface area, which makes them behave differently to non-nano versions of the same material. It can make them more mobile, more reactive and potentially more toxic, depending on shape, size, type, how a substance is released into the environment and its concentration.

And released into the environment they are, on a massive scale. According to Avicenn, the release of nanos is most likely during manufacture or disposal, but it can also happen when items are washed which is known to occur with fabrics containing nanosilver. Sewage systems cannot trap them and they end up in the ocean: the OECD says even advanced wastewater-treatment plants cannot deal with nanoparticles.

From a health perspective, inhalation is the most harmful route of exposure to nanos such as TiO2 for factory workers and consumers. Avicenns tests concluded that the average particle size was 4.9nm, and all 300 particles analysed were below the official nano threshold of 100nm.

Ikea insisted its own tests showed the TiO2 particles were properly bound to the fabric and pose no risk to customers, and said it took workers safety extremely seriously. The firm has not referred to them as nanoparticles, and said that once integrated into textile surfaces there was no good standard method to measure the particle size distribution of a material, acknowledging that EU definitions of nanomaterials were under review.

We recognise that the tests and measurements of nano-particles are complex, especially for materials containing particles that tend to form agglomerates, it said.

As for Ikeas curtains shedding TiO2 nanoparticles when washed or discarded, Ikea said it was confident that the treatment is properly bound to the fabric, and therefore we do not see a risk of inhaling the treatment, but acknowledged that as with any textile, parts of the textile can come off during use or washing.

Many nanos do not persist for long in the environment. However, because they are consistently being discharged, levels remain fairly constant. Nanos are pseudo-persistent because they degrade quite quickly but they keep entering the environment, Voulvoulis says.

His main concern is whether nanos become carriers for other compounds, a subject of scientific debate. In 2009, Spanish scientists suggested nanos could bind to and transport toxic pollutants, and possibly be toxic themselves by generating reactive free radicals. If other toxic pollutants latch on to nanos surfaces, they argued, marine plants and animals could absorb them more easily.

Other scientists suggest the opposite: that organic matter in sewage coat nanoparticles, rendering them less active. And others fear nanos could trigger toxic cocktail effects making them more harmful in combination than individual substances would be separately.

So far, synthetic nanomaterials are relatively dispersed in the sea, and unlikely to significantly affect marine animals, says Dr Tobias Lammel of Gothenburg University, who has studied copper nanos. But he warns: Its possible that the concentration of some manufactured nanomaterials in the marine environment will increase It is important to keep an eye on this.

Given the huge question marks, Avicenn wants more stringent regulations on nanos, and more caution in product design. Companies are eager to sell innovative and fancy products, but they must thoroughly assess their benefits-risks balance at each step of the life-cycle of the products, says Mathilde Detcheverry, Avicenns policy manager.

From August, the EU will ban use of TiO2 nanos in food (where it is called E171) and the European Commission recently announced that 12 nanomaterials would soon be prohibited in cosmetics.

Detcheverry says: As scientific knowledge about the environmental and health impacts of engineered nanos such as silver and titanium dioxide advances, we need to make sure nanos are only allowed for specific and essential uses in order to minimise any adverse effects at the source and [ensure they are] not released uncontrollably.

Two years after the release of Ikeas Gunrid curtains, Avicenn tried to buy more for further tests, but they had been withdrawn from sale.

Ikea told the Guardian that Gunrid remained safe to use as a traditional curtain but it was withdrawn because the functionality was not as effective as expected. If thats true for example, that despite TiO2 having proven photocatalytic properties and being used in self-cleaning and air-purifying products, its efficacy on curtains could be localised and not powerful then at the very least Ikeas experience suggests nanoparticles benefits may not outweigh the potential and frequently unknown risks, Detcheverry says.

Nanoparticles are often promoted as silver bullets against pollution or bacteria, she says, but we must make sure that the cure is not worse than the disease.

Gunrid was just one product of many thousands that use nanoparticles. As Ikeas Affonso says in the video: Whats so great about Gunrid is that this technology could be applied to any textile.

This article was amended on 26 April 2022 to correct the spelling of Gothenburg.

More here:
Nano state: tiny and now everywhere, how big a problem are nanoparticles? - The Guardian

Posted in Nano medicine | Comments Off on Nano state: tiny and now everywhere, how big a problem are nanoparticles? – The Guardian

Three UNC-Chapel Hill faculty elected as members of the American Academy of Arts & Sciences – UNC News : UNC News – UNC News

Posted: May 2, 2022 at 2:47 am

(Chapel Hill, N.C. April 28, 2022) UNC-Chapel Hill faculty members Ralph S. Baric, Virginia Gray, and Jenny P. Ting were elected as members of the American Academy of Arts & Sciences on April 28.

Ralph Baric is the William R. Kenan Jr. Distinguished Professor in the Department of Epidemiology and Professor in the Department of Microbiology and Immunology. His research specializes in coronaviruses and infectious diseases using molecular, genetic and biochemical approaches.

Virginia Gray is professor emerita in the College of Arts & Sciences political science department. Her teaching experience includes a variety of American politics courses, such as interest groups, state politics, fieldwork in the legislature and public policy. Her research spans a variety of topics, including state interest groups and public policy.

Jenny Ting is the William R. Kenan Jr. Distinguished Professor in the Department of Genetics. Her research focuses on using cutting edge ideas and technology to understand disease-relevant issues such as innate immunity, gene regulation, and inflammation among others.

The three join the 39 UNC-Chapel Hill faculty previously elected to the American Academy of Arts and Sciences.

Founded in 1780, the American Academy of Arts and Sciences is both an honorary society and an independent research center. Members are elected from across disciplines, professions and perspectives to examine new ideas, address issues and advance the public good. Membership is an honor, and also an opportunity to shape ideas and influence policy in areas as diverse as the arts, democracy, education, global affairs, and science. said Chair of the Academys Board of Directors Nancy C. Andrews. Over 13,500 members have been elected since its founding.

The new members join a distinguished group of individuals elected to the Academy before them. Notable members include Benjamin Franklin in 1781, Charles Darwin in 1874, Albert Einstein in 1924, Martin Luther King, Jr. In 1966, Stephen Jay Hawking in 1984, and Condoleezza Rice in 1997.

The complete list of individuals elected in 2022, including 37 International Honorary Members from 16 countries, is available here.

Go here to see the original:
Three UNC-Chapel Hill faculty elected as members of the American Academy of Arts & Sciences - UNC News : UNC News - UNC News

Posted in Molecular Genetics | Comments Off on Three UNC-Chapel Hill faculty elected as members of the American Academy of Arts & Sciences – UNC News : UNC News – UNC News

6 UH faculty recognized among top scientists in ecology, evolution | University of Hawaii System News – University of Hawaii

Posted: May 2, 2022 at 2:47 am

Mark Hixon diving.

Six faculty members at the University of Hawaii at Mnoa have been listed among the top 1,000 scientists in the disciplines of ecology and evolution. In the top 1% of their fields, UH scientists were ranked among 166,880 colleagues evaluated by Research.com.

School of Ocean and Earth Science and Technologys (SOEST) Hawaii Institute of Marine Biology (HIMB) Researcher Brian Bowen; SOEST Pacific Biosciences Research Center Professor Emeritus Michael Hadfield; School of Life Sciences Professor Mark Hixon; SOEST Department of Oceanography Professor Emeritus Craig Smith; SOEST HIMB Researcher Robert Toonen; and SOEST HIMB former director, the late Ruth Gates, were ranked among the worlds top scientists for ecology and evolution.

The ranking is constructed using the H-index data (a metric for evaluating the cumulative impact of an authors scholarly output and performance) gathered by Microsoft Academic and included only prominent scientists with an H-index of at least 30 for scientific papers published in the field of ecology and evolution.

This recognition demonstrates the superior quality of work by our faculty, providing further evidence of our status as one of the worlds great research universities, said UH Mnoa Provost Michael Bruno. Their research in ecology, conservation, and human impacts on the environment have led the way toward countless impactful discoveries, and we are proud to have them as part of our UH ohana.

Bowens research program is designed to resolve the origins of marine biodiversity in the service of conservation. Since joining the HIMB faculty in 2003, he has conducted range-wide genetic inventories of Hawaiian and Indo-Pacific reef fishes to inform the design of marine protected areas. Bowen is co-author of the best-selling textbook Diversity of Fishes, which will be published in a third edition later this year.

Hadfields scientific interests lie mainly in marine invertebrate larval ecology and metamorphosis and the roles of marine bacteria films as cues for larval settlement. His long-term research goals are aimed at understanding the factors that determine where larvae of bottom-living invertebrate animals settle and metamorphosea key to understanding how seafloor communities are established and maintained on all surfaces under salt water.

Hixons expertise is the ecology and conservation biology of coral reefs, presently focusing on how seaweed-eating fishes benefit corals. He has also studied kelp forest fishes, hummingbird behavior, deep-sea communities, fisheries ecology, and the invasion of the Caribbean Sea by Pacific lionfish.

Smith has strong interests in biodiversity, disturbance ecology and human impacts in seafloor ecosystems. He has conducted research in Antarctica, mangroves, submarine canyons, whale-fall communities, cold seeps, continental slopes, and abyssal plains to obtain a broad perspective of natural and stressed marine ecosystems. His most recent work includes assessing the impacts of climate warming on Antarctic fjord ecosystems, and designing marine protected areas to mitigate biodiversity loss from deep-sea mining.

Toonen has used lab and field experiments, molecular genetics, and computer modeling and more in an effort to address a variety of biological questions. From assessing cues for larval settlement to population genetics of marine invertebrates, sharks and turtles, to coral bleaching and conservation, Toonen approaches research from an ecological perspectiveto scale up from genes to individuals to populations.

Gates was a tireless innovator and advocate for coral reef conservation. Coral reefs around the world have experienced massive die off as a result of warming ocean temperatures, increasing acidity, pollution runoff from land and other threats. The focus of her most recent research was creating super corals, coral species occurring naturally in the ocean that could be trained to become more resilient to these harsh conditions. Gates passed away in 2018.

This recognition is an example of UH Mnoas goal of Excellence in Research: Advancing the Research and Creative Work Enterprise (PDF), one of four goals identified in the 201525 Strategic Plan (PDF), updated in December 2020.

For more information, see Research.com.

Read the original post:
6 UH faculty recognized among top scientists in ecology, evolution | University of Hawaii System News - University of Hawaii

Posted in Molecular Genetics | Comments Off on 6 UH faculty recognized among top scientists in ecology, evolution | University of Hawaii System News – University of Hawaii

Virus or Bacteria? Study Reveals Promising Test Results – Contagionlive.com

Posted: May 2, 2022 at 2:47 am

When patients visit a healthcare provider complaining of respiratory illness, its often difficult for the provider to distinguish between a bacterial infection necessitating antibiotics and a viral infection. Because of this lack of clarity, providers sometimes will prescribe antibiotics as a just in case strategy. Unfortunately, indiscriminate use of antibiotics has resulted in antibiotic resistance and increased side effects. Even in cases where antibiotics are warranted, experts recommend the shortest course of antibiotics possible.

A recent prospective multicenter diagnostic study published in JAMA Network Open discussed a point-of-care test measuring host-gene expression that can differentiate between a bacterial infection and a viral one. Data on patients who visited US emergency departments with fever and acute respiratory syndrome symptoms was collected over a 5-year period from 2014 to 2019, with data on additional COVID-19 patients seen in the ER between March and December 2020. A total of 616 patients were included in the initial analysis, with 33 patients in the COVID-19 cohort.

Participants enrolled in the trial gave blood samples which were analyzed by a host response bacterial/viral test. The test, which takes about 45 minutes, measures the expression of 45 host messenger RNA targets. Based on the results, scientists were able to determine whether an infection was bacterial or viral with a high degree of accuracy.

The primary analysis included 334 subjects in whom the scientists were highly confident of the infection type based on microbiological test results or the analysis of a clinical panel. In this analysis, the test showed a sensitivity of 89.8% (95% confidence interval, 77.8%-96.2%) and a specificity of 82.1% (95% CI, 77.4%-86.6%) for bacterial infection. A secondary analysis looked at all 616 participants, including subjects whose infection source was less clear. This yielded a sensitivity of 86.4% (95% CI, 79.6%-92.5%) and a specificity of 71.9% (95% CI, 67.7%-75.9%) for bacterial infection. In both cases, the results were significantly more accurate than tests that measured the level of procalcitonin, a commonly used biomarker of bacterial infection.

Although symptoms of bacterial and viral infections are often quite similar, the microbes themselves are distinct. Because viral and bacterial pathogens are so different, our immune systems have evolved different ways of dealing with them, Ephraim Tsalik, MD, MHS, PhD, associate professor in the department of molecular genetics and microbiology at Duke University School of Medicine, and an author of the study, told Contagion. His team of scientists used machine learning to help them winnow down tens of thousands of genes to zoom in on the few dozen that exhibited changes indicating the immune system was responding to either a viral or bacterial infection.

In Tsaliks view, the greatest benefit of the test is its ability to confirm that an infection is not bacterial, as that frees healthcare providers from the pressure to prescribe antibiotics. "A lot of times, what patients come in for is reassurance, he said. If providers let patients know that their infection is likely viral and will run its course without intervention, instances of unnecessary antibiotic use can be avoided. While the test may miss a few infections that actually are bacterial, Tsalik stressed that patients can always return to providers and get a prescription for antibiotics should their clinical course indicate it.

The science behind the host response bacterial/viral test lends itself to any environment, according to Tsalik, although barriers such as cost, lack of personnel expertise, and workflow issues may hamper its distribution, at least in the near term. The hope is to make this available in a form that would be widely available, he said.

View original post here:
Virus or Bacteria? Study Reveals Promising Test Results - Contagionlive.com

Posted in Molecular Genetics | Comments Off on Virus or Bacteria? Study Reveals Promising Test Results – Contagionlive.com

Presenting the Government Hall of Fame Class of 2022 – GovExec.com

Posted: May 2, 2022 at 2:47 am

Three years ago, Government Executive created the Government Hall of Fame with a simple purpose: to recognize those peoplesome world-famous, others virtually unknownwho have made historic advances in achieving governments aim of serving the American people. Since then, a distinguished group of heroes, ranging from Clara Barton to Anthony Fauci, have been inducted into the hall.

This year, were taking the Hall of Fame to a whole new level by combining it with the Federal 100, an annual list prepared by FCW of women and men who personify whats possible in the federal government, especially in the area of information technology. Since Government Executive and FCW have joined forces under the GovExec corporate banner, we decided it was only natural to bring the two prestigious awards programs together in one gala. That event, An Evening of Honors, will take place on May 12 at the Washington National Cathedral.

Here are the members of the Class of 2022 of the Government Hall of Fame:

Francis Collins

An M.D. and a Ph.D. in physical chemistry, Collins devoted much of his life to molecular genetics and made several important discoveries, which led to his appointment in 1993 to lead the agency managing the Human Genome Project. The National Human Genome Research Institute finished its work in 2003. In 2009, President Obama appointed him director of the National Institutes of Health, where he served under three different administrations. He retired at the end of 2021. Collins was awarded the Presidential Medal of Freedom by President George W Bush in 2007.

Patricia Roberts Harris

Harris was the first African-American woman to hold a Cabinet position. She served as secretary of Housing and Urban Development and later headed the Department of Health, Education and Welfare (which became Health and Human Services while she was leading it) in the Carter administration. Earlier in her career, Harris served as ambassador to Luxembourg, the first Black woman to be named to such a post. She arranged for an endowment to be created afterher death in 1985 to provide stipends for Howard University students to participate in public service internships.

Walter Hollis

Hollis served for 56 years at the Defense Department, including 26 years as the deputy undersecretary of the Army for operations research until his retirement at the age of 80 in 2006. He was the highest ranking civil servant in the Army and in charge of Operations Research, Systems Analysis and Operational Test and Evaluation. This made him an extremely influential figure in the system development and procurement process. Collins was highly respected for his willingness to buck the Army hierarchy to avoid costly mistakes.

Shirley Ann Jackson

A renowned theoretical physicist, Jackson is the first African-American woman to receive a doctorate from M.I.T. in any subject. In 1995 she became both the first woman and first African-American to serve as chairperson of the Nuclear Regulatory Commission. During her tenure, she instituted crackdowns on the nuclear power industrys violations and assured NRCs commitment to public health and safety.She was awarded the National Medal of Science, the nations highest honor for contributions in science and engineering, by President Obama in 2016.

Charles McGee

A member of the famed African American fighter pilot unit known as the Tuskegee Airmen, McGee flew a total of 409 combat missions in World War II, the Korean conflict and the Vietnam War. In the process, he won the Distinguished Flying Cross, the Legion of Merit, the Bronze Star, the Air Medal and the Presidential Unit Citation. In 2020, President Trump promoted him from the rank of colonel to brigadier general. McGee died at the age of 102 in 2022.

Ely S. Parker

In 1857, Parker, a Seneca Indian who was educated as both a lawyer and an engineer, was appointed by the Treasury Department to oversee the construction of a customs house in Galena, Ill. There he became acquainted with Ulysses S. Grant, and served on the generals staff during the Civil War. In that role, Parker made the formal copy of the terms of surrender presented at Appomattox. When Grant was elected president, he appointed Parker commissioner of Indian affairs, the first Native American to hold the post.

Elmer Staats

Staats shaped the Government Accountability Office (then known as the General Accounting Office) over four presidential administrations. In a federal career spanning 50 years, he worked in the Bureau of the Budget beginning under President Franklin Roosevelt in 1939. After several promotions, he became comptroller general in 1966. There he broadened GAOs work, conducting high-impact oversight of federal elections, Vietnam War spending, energy, consumer protection and other issues.

Marshalyn Yeargin-Allsop

A pioneer in tracking the prevalence of autism among children, Yeargin-Allsop is chief of the developmental disabilities branch at the Centers of Disease Control and Prevention. After joining the CDC in 1981, she saw the need for better information on developmental disabilities among children. She devised an innovative study to address the issue, leading to a movement to provide better services to children with such disabilities. Yeargin-Allsop was the recipient of the 2018 career achievement award in the Service to America Medals program.

IN GOOD COMPANY

The members of the distinguished class of 2022 join those who have already been inducted into the Government Hall of Fame:

THE SELECTION COMMITTEE

This years inductees into the Government Hall of Fame were chosen by a panel made up of former federal officials and public administration experts:

See more here:
Presenting the Government Hall of Fame Class of 2022 - GovExec.com

Posted in Molecular Genetics | Comments Off on Presenting the Government Hall of Fame Class of 2022 – GovExec.com

Next Generation Sequencing (NGS) Market Analysis by Growth Developments, Competitive Research Outlook and Strategies 2021 to 2030 Queen Anne and…

Posted: May 2, 2022 at 2:47 am

Next generation sequencing (NGS) is a novel procedure for sequencing genomes at low costs and high speed with improved efficiency.The global next generation sequencing market accounted for $3,567 million in 2015, and is anticipated to reach $12,801 million by 2022, registering a CAGR of 19.9% from 2016 to 2022.NGS also known as deep sequencing and parallel sequencing is a technology that has revolutionized molecular biology and genomics research. It is a high throughput, non-Sanger based sequencing method.

Next generation sequencing has made sequencing of genomes very rapid and cost-effective. Through this method, billions of DNA strands can be sequenced efficiently. Next generation sequencing has made it possible to conveniently sequence whole genomes, and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. Next generation sequencing can be utilized through varied interventions such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.

Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=27027

Market Statistics:

The file offers market sizing and forecast throughout 5 primary currencies USD, EUR GBP, JPY, and AUD. It helps corporation leaders make higher choices when foreign money change records are available with ease. In this report, the years 2020 and 2021 are regarded as historic years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2030 are viewed as the forecast period.

The Centers for Medicare and Medicaid Services report that US healthcare expenditures grew by 4.6% to US$ 3.8 trillion in 2019, or US$ 11,582 per person, and accounted for 17.7% of GDP. Also, the federal government accounted for 29.0% of the total health expenditures, followed by households (28.4%). State and local governments accounted for 16.1% of total health care expenditures, while other private revenues accounted for 7.5%.

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the markets future growth.

Technological advancements in sequencing platforms, surge in applications of next generation sequencing, and increase in genome mapping programs drives the global next generation sequencing market. In addition, rise in awareness pertaining to next generation sequencing and rise in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, ethical & legal limitation related to next generation sequencing, and standardization concerns in sequencing procedures impede the market growth. Furthermore, use of cloud computing as a potential data management service and untapped emerging economies offer lucrative opportunities for the market players.

Get a Request Sample Report with Table of Contents:https://reportocean.com/industry-verticals/sample-request?report_id=27027

The next generation sequencing market is segmented based on product, application, technology, end user, and geography. Based on product, the market is segmented into consumables, platforms, and services. The consumables product segment is further classified on the basis of sample preparation consumables and other consumables. The sample preparation consumables are further segmented into DNA fragmentation, end repair, A-Tailing & size selection, library preparation & target enrichment and quality control. The platform NGS product segment is bifurcated into HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II & Sequel System, and other sequencing platforms. The services segment is divided into sequencing services and data management. In the NGS product segment, consumables occupied dominant share in 2015, and the segment is expected to maintain this trend during the forecast period. This is attributed to the fact that they are widely used throughout the sample preparation process and other pre-requisite steps of NGS.

Based on application, this market is bifurcated into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, agriculture & animal research, and other applications. The biomarkers & cancer application was the highest revenue contributor in 2015, while the personalized medicine segment is anticipated to grow at the highest rate. The growth for this segment is due to increase in investment in R&D throughout the world along with surge in awareness about NGS applications in precision medicine. Based on technology, the next generation sequencing technology market is classified into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, and other technologies. Sequencing by synthesis technology held the greatest share in 2015 and this trend is estimated to continue throughout the study period as this technology allows both short and long insert paired end reads for high resolution genome sequencing and structural variation detection, sequence assembly & others respectively..

Geographically, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the next generation sequencing market in 2015, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to the higher buying power, availability, and applications that favor the utilization of NGS in this region. There is also an increase in agreements and collaborations between different market players and health centers to promote and utilize NGS in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in R&D facilities, available disposable income, and rapidly developing economic conditions.

Get a Request Sample Report:https://reportocean.com/industry-verticals/sample-request?report_id=27027

Product development is the key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global next generation sequencing market.

KEY PLAYERS PROFILED

Illumina, Inc.Thermo Fisher Scientific, Inc.Pacific Biosciences of California, Inc.Beijing Genomics InstituteQiagen N.V.454 Life Sciences Corporation (Roche Holding AG)Agilent Technologies, Inc.Perkinelmer, Inc.Genomatix GmbHPierianDx.

A release on June 8th, 2021, by the Bureau and Economic Analysis and U.S. The Census Bureau reports the recovery of the U.S. market. The report also described the recovery of U.S. International Trade in July 2021.In April 2021, exports in the country reached $300 billion, an increase of $13.4 billion. In April 2021, imports amounted to $294.5 billion, increasing by $17.4 billion. COVID19 is still a significant issue for economies around the globe, as evidenced by the year-over-year decline in exports in the U.S. between April 2020 and April 2021 and the increase in imports over that same period of time. The market is clearly trying to recover. Despite this, it means there will be a direct impact on the Healthcare/ICT/Chemical industries.

KEY MARKET BENEFITS

The study provides an in-depth analysis of the global next generation sequencing market along with the current trends and future estimations to elucidate the imminent investment pockets.The report presents quantitative analysis of the market for the period of 2014-2022 to enable stakeholders to capitalize on the prevailing market opportunities.Extensive analysis of the market based on product type assists in understanding the trends in the industry.Key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry

Next generation sequencing Market Key Segments:

By Product

ConsumablesSample Preparation ConsumablesDNA Fragmentation, End Repair, A-Tailing and Size SelectionLibrary Preparation & Target EnrichmentQuality ControlOther ConsumablesPlatformsHiSeqMiSeqIon TorrentSOLiDPacbio Rs II and Sequel SystemOther Sequencing PlatformsServicesSequencing ServicesRNA SequencingWhole Exome SequencingWhole Genome SequencingTargeted SequencingChip SequencingDe Novo SequencingMethyl SequencingData Management ServicesNGS Data Analysis ServicesNGS Data Analysis Software & WorkbenchesNGS Storage, Management and Cloud Computing Solutions

By Application

DiagnosticsBiomarkers and CancerReproductive HealthPersonalized MedicineAgriculture and Animal ResearchOther Applications

By Technology

Sequencing by SynthesisIon Semiconductor SequencingSequencing by LigationPyrosequencingSingle Molecule Real Time SequencingOther Technologies

By End User

Academic & Government Research InstitutesPharmaceutical CompaniesBiotechnology CompaniesHospitals & Clinics

Request full Report-https://reportocean.com/industry-verticals/sample-request?report_id=27027

By Geography

North AmericaU.S.CanadaMexicoEuropeGermanyFranceUKItalySpainRest of EuropeAsia-PacificJapanChinaAustraliaIndiaSouth KoreaTaiwanRest of Asia-PacificLAMEABrazilTurkeySaudi ArabiaSouth AfricaRest of LAMEA

Other players in the value chain include (profiles not included in the report)

Eurofins ScientificGatc Biotech AGMacrogen, Inc.Oxford Nanopore Technologies, Ltd.Bio-Rad Laboratories, Inc.DNASTAR, Inc.Biomatters Ltd.Partek Inc.New England Biolabs, Inc.Myriad Genetics, Inc.

Table of Content:

Key Questions Answered in the Market Report

How did the COVID-19 pandemic impact the adoption of by various pharmaceutical and life sciences companies? What is the outlook for the impact market during the forecast period 2021-2030? What are the key trends influencing the impact market? How will they influence the market in short-, mid-, and long-term duration? What is the end user perception toward? How is the patent landscape for pharmaceutical quality? Which country/cluster witnessed the highest patent filing from January 2014-June 2021? What are the key factors impacting the impact market? What will be their impact in short-, mid-, and long-term duration? What are the key opportunities areas in the impact market? What is their potential in short-, mid-, and long-term duration? What are the key strategies adopted by companies in the impact market? What are the key application areas of the impact market? Which application is expected to hold the highest growth potential during the forecast period 2021-2030? What is the preferred deployment model for the impact? What is the growth potential of various deployment models present in the market? Who are the key end users of pharmaceutical quality? What is their respective share in the impact market? Which regional market is expected to hold the highest growth potential in the impact market during the forecast period 2021-2030? Which are the key players in the impact market?

Inquire or Share Your Questions If Any Before the Purchasing This Report https://reportocean.com/industry-verticals/sample-request?report_id=27027

About Report Ocean:We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in todays competitive environment. Report Ocean is a one-stop solution for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:Report Ocean:Email:sales@reportocean.comAddress: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 UNITED STATESTel:+1 888 212 3539 (US TOLL FREE)Website:https://www.reportocean.com

Read the original post:
Next Generation Sequencing (NGS) Market Analysis by Growth Developments, Competitive Research Outlook and Strategies 2021 to 2030 Queen Anne and...

Posted in Molecular Genetics | Comments Off on Next Generation Sequencing (NGS) Market Analysis by Growth Developments, Competitive Research Outlook and Strategies 2021 to 2030 Queen Anne and…

Overview of EGFR Exon 20 and Molecular Testing in NSCLC – Curetoday.com

Posted: May 2, 2022 at 2:47 am

Transcript:

Estelamari Rodriguez, M.D., MPH: Hello, and welcome to Cure Expert Connections on exon 20 [EGFR mutations] in non-small cell lung cancer. Im Estelamari Rodriguez, M.D., MPH, and Im associate director of community outreach and co-lead of the Thoracic Disease Group of the University of Miami Sylvester Comprehensive Cancer Center. Id like to welcome Katina Bland. Please introduce yourself, Katina.

Katina Bland: Absolutely. Thank you for having me, Dr. Rodriguez. My name is Katina Bland, and I am pleased to be here today with you. I am a member of the Exon 20 Groups advisory council, and I also am the chair of the Speakers Bureau. I have the privilege of also being the care partner for my beloved husband, Martell Bland, who also was an exon 20 patient with ICAN [International Cancer Advocacy Network]. My husband and I established the educational program called the Martell and Katina Bland Patient Education Program.

Estelamari Rodriguez, M.D., MPH: Thank you for all youve done. I really believe that, we have known about EGFR mutations for a long time, but we are finding that there are subgroups of patients with EGFR mutations that we didnt know how to treat because we didnt understand that all these receptors, all these mutations, can respond differently to treatment. I just wanted to cover a little about the significance of EGFR mutations. EGFR has been well established as a very common driver mutation for non-small cell lung cancer. It accounts for about 20% to 25% of mutations in non-small cell lung cancer. The EGFR [exon] 20 insertion mutation, which we previously had lumped together with all the EGFRs, we have known that patients who have this exon 20 insertion mutation either get missed in the process of diagnosis or they get treated with the existing EGFR targets that were previously used for the common mutations, and they were not responding as well.

There has been a lot of research in exon 20 insertion mutations to understand what would be the best target for these patients. These are seen in 4% to 12% of EGFR-mutated cases. We know that the more common [mutations] that have been tested in the larger trials with the older generation drugs are deletion 19, and L858R on exon 21, but this particular exon 20 insertion is important to recognize because now we have treatment options. Katina, I wanted to ask you a bit about when your husband was diagnosed. How was that discussion of understanding his mutation, and at what point had they figured that out for him?

Katina Bland: Well, we figured that out relatively soon because our oncologist ordered NGS testing for him and that was critical. NGS stands for next-generation sequencing testing. It is absolutely critical that we use that form of testing because that is more accurate than any other form of testing you may have heard of, including something thats known now as PCR [polymerase chain reaction] testing. Most people have heard of that as it relates to the COVID-19 era now. PCR testing leaves quite a bit undiagnosed, maybe 50% of EGFR exon 20 insertion mutations are not caught with PCR testing. It is critical that the platform for testing and the standard needs to be the NGS testing because biomarker testing is the way to go, to have your tissue and your liquid biopsies tested in that method.

Estelamari Rodriguez, M.D., MPH: Im glad to hear that you and your husband had that information at the beginning of the treatment because, unfortunately, many patients either dont get the right test up front or it gets missed because theres an urgency to treat, and patients have been started on chemo [chemotherapy] and immunotherapy, where we know that patients who have driver mutations will be better with targeted therapy. It is very critical to have this at the time of diagnosis. Just to summarize what you said, the NCCN [National Comprehensive Cancer Network], which sets the standards for cancer care in the United States and internationally, has outlined comprehensive molecular testing, molecular profiling of the tumor, as standard. We have about nine targets that today are considered druggable, for which we have a drug, and we have many that are in development. Having as much information as possible about the tumor genetics and the molecular drivers will open doors for treatments that are available today.

Some of the treatments we will discuss today are very recent. If you dont do this test, when the drug gets approved, you will have missed the opportunity. You mentioned something really important; I think its very hard for patients. You get these reports that, even for physicians, are very hard to comprehend. Sometimes they have a summary slide, and you dont know what type of test was done. Was it an immunohistochemistry, which is a very simple expression of a protein? Or was it a PCR, which you mention can be just a single gene evaluation? Or was it an in-depth next-generation sequencing, which is more comprehensive and looks at the whole genome of that tumor? Those are the ones that would allow us to pick specific findings like the EGFR 20 insertion.

Transcript edited for clarity.

More:
Overview of EGFR Exon 20 and Molecular Testing in NSCLC - Curetoday.com

Posted in Molecular Genetics | Comments Off on Overview of EGFR Exon 20 and Molecular Testing in NSCLC – Curetoday.com

Dog study shows there’s a lot more to behavior than just breed – ASU News Now

Posted: May 2, 2022 at 2:47 am

April 29, 2022

A genetic study of 2,155 purebred and mixed-breed dogs combined with 18,385 owner surveys has challenged existing notions about dog breed stereotypes and personality types.The study identified 11 locations along the canine genome that were strongly associated with behavior, none of which were specific for breed, suggesting that these personality traits predate modern canine breeding by humans.

Using a really powerful model, these findings provide compelling support for the fact that complex traits, like behavior or personality, may have some genetic contribution, but that contribution is distributed across so many genes with really tiny effects," said Arizona State University School of Life Sciences Assistant Professor Noah Snyder-Mackler, who contributed to the study in a collaboration with investigators at the UMass Chan Medical School, includingElinor Karlsson, who led the study that was published in a recent issue of Science. "This means that while we can predict how biddableBiddability refers to a dog's ability to respond to human direction. a dog is on average, we will do a pretty terrible job predicting the biddability of a single dog based on their genotype, and definitely not their breed. It points to the fact that much of these complex traits are strongly impacted by the lived experiences of each individual.

Noah Snyder-Mackler

Canine behavioral disorders are often proposed as a natural model for human neuropsychiatric disorders. Compulsive disorders, for instance, are often observed to manifest similarly in both humans and dogs. Thanks to the power of current DNA sequencing technology and the close relationship between pet and owner, canine genome-wide association studies (GWAS) have the potential to identify unique genetic areas in the dog genome that could lead to new insights into similar genes in humans. Karlsson and colleagues show that large-scale GWAS in dogs can yield genetic loci associated with behavioral traits.

Although friendliness is the trait we commonly associate with golden retrievers, what we found is that the defining criteria of a golden retriever what makes a golden retriever a golden retriever are its physical characteristics, the shape of its ears, the color and quality of its fur, its size; not whether it is friendly, said Karlsson, associate professor of molecular medicine at UMass Chan Medical School.

While genetics plays a role in the personality of any individual dog, the specific dog breed is not a good predictor of those traits, explained Karlsson, who is also the director of the Vertebrate Genomics Group at the Broad Institute of the Massachusetts Institute of Technology and Harvard University. A dogs personality and behavior are shaped by many genes as well as their life experiences. This makes them difficult traits to select for through breeding. For the most part, pure breeds are only subtly different from other dogs. A golden retriever is only marginally more likely to be more friendly than a mixed-breed or another purebred dog, such as a dachshund.

The story of how modern-day dog breeds emerged is a relatively short one in evolutionary terms, contrasted against the history of dog domestication from prehistoric wolves. Genetic research pegs the change from wolf to dog at about 10,000 to 15,000 years ago. Humans didnt begin intentionally breeding dogs until roughly 2,000 years ago, when they were being selected for work roles such as hunting, guarding and herding. It wasnt until the Victorian era in the 1800s that humans began selecting dogs consistently for the physical appearance and aesthetic traits that today we commonly associate with modern breeds.

Yet modern dog breeds are often credited with characteristics and temperaments (bold, affectionate, friendly, trainable) that correlate to their ancestral function (herding, guarding or hunting). Likewise, the breed ancestry of dogs is assumed to be predictive of temperament and behavior. DNA tests are even marketed as tools for dog owners to learn about a pets individual personality. However, there is a lack of genetic studies linking behavioral tendencies to ancestry or other genetic, heritable factors.

By pairing genome-wide association mapping technologies with pet owner surveys obtained through Darwins Ark, an open-source database of owner-reported canine traits and behaviors, Karlsson and first author Kathleen Morrill, a PhD student in the Morningside Graduate School of Biomedical Sciences at UMass Chan, explored the complicated relationship between modern canine breeds and behavioral characteristics.

Genome-wide association studies (GWAS) are an approach used in genetics research to try to associate specific areas of variation in the human genome that align with certain phenotypes. Taking whole genome sequences from hundreds of thousands of people with the same disease, for instance, researchers look for common genetic variations among these people to pinpoint broad areas in the genome that may be predictive or causative for specific diseases.

Karlsson, Morrill and their colleagues applied this same strategy to correlate areas of the canine genome with certain behavioral traits or characteristics. Pet owners who participate in Darwins Dogs provide scientists with saliva samples from their dogs. Researchers run whole genome sequencing on these samples to generate a robust genetic data set for investigation. Additionally, for this study, owners filled out 12 short surveys totaling 117 questions about their pets behaviors and physical traits. Combined, this data provides the basis for scientists to associate genetics with owner-reported behavior.

Given a large enough sample size, GWAS are a really powerful tool for learning about genetics, said Morrill. We only get that size by looking at all dogs not just purebred dogs, but mixed-breed dogs too. We compare all these DNA sequences computationally, using complex algorithms, to identify areas of differences and commonalities that might be of interest.

Karlsson and Morrill collected more than 2,000 canine genomes and 200,000 survey answers through Darwins Dogs. Because of existing stereotypes about dog behavior and breeds, Karlsson and Morrill designed the study to account for possible owner bias, in part, by establishing standard definitions for reporting and rating canine behavioral traits such as biddability (a dog response to human direction), dog-human sociability (a dogs comfort with people, including strangers) and toy-directed motor patterns (a dogs interest and interaction with toys), among others. Physical and aesthetic trait standards were pulled from those published by the American Kennel Club.

Genetic research pegs the change from wolf to dog at about 10,000 to 15,000 years ago. Photo courtesy of Noah Snyder-Mackler

Behavioral data was analyzed across owner-reported breeds and genetically detected breed ancestries. The results of these tests, which included data from 78 breeds, showed that while breed explained some minor variation in behavior, its contributions were relatively small (9%). For certain behavioral traits, such as toy-directed motor patterns, age was a better predictor of behavior: Younger dogs were more likely to score higher in this category. For specific survey items, such as lifts leg to urinate, a dogs sex was the best predictor of behavior. Physical traits like coat color were more than five times more likely to be predicted by breed than behavioral traits.

Additionally, investigators failed to find behaviors that were exclusive to any one breed. Even in Labrador retrievers, which had the lowest propensity for howling, 8% of owners reported their Labradors sometimes howl. Likewise, while 90% of greyhound owners reported that their dogs never bury their toys, three owners described greyhound dogs as frequent buriers.

Complementing the survey analysis of breeds to measure breed-behavioral propensities, the researchers also leveraged the genetic ancestry of highly mixed-breed dogs to test whether behavior is heritable in a breed-dependent manner. In some cases, heritable behavioral traits like biddability are somewhat more likely to correlate with breed, even if mixed a few generations back. In the case of purebred dogs, ancestry can make behavioral predictions somewhat more accurate. For less heritable, less breed-differentiated traits, like agonistics threshold, which measures how easily a dog is provoked by frightening, uncomfortable or annoying stimuli, breed is almost useless as a predictor of behavior.

A comparison of dog genomes was performed to identify genetic variations tracking along breed, as well as along individual physical and behavioral traits. Karlsson and Morrill identified 11 locations on the dog genome strongly associated with behavioral differences, none of which were specific for breed, and another 136 suggestively associated with behavior. The genetic differences between breeds such as golden retrievers, Chihuahuas, Labrador retrievers, German shepherd dogs and others, primarily affected genes that control coat color, fur length and other physical traits far more than breed differences affected behavioral genes.

Overall, Karlsson and Morrill found that behavioral characteristics were influenced by multiple factors, including environment and individual genetics, but that modern breed classification played a modest role in the outcome.

The majority of behaviors that we think of as characteristics of specific modern dog breeds have most likely come about from thousands of years of evolution from wolf to wild canine to domesticated dog, and finally to modern breeds, said Karlsson. These heritable traits predate our concept of modern dog breeds by thousands of years. Each breed inherited the genetic variation carried by those ancient dogs, but not always at exactly the same frequencies. Today, those differences show up as differences in personality and behavior seen in some, but not all, dogs from a breed.

For ASU's Snyder-Mackler, the study represents a significant opening salvo demonstrating the power of using modern genomic tools to study companion animals to gain new insights intothe causes and consequences of variation in the social environment, from the molecular to the organismal levels.

"This study would not have been possible without the Herculean efforts to generate a massive behavioral dataset and combine that with whole genome sequencing of almost 2,000 dogs without spending an arm and a leg. This was achieved by using some really cool computational approaches to try and gain as much information from each dog with as little sequencing as possible, which we found worked better than the most common approach to genotyping microarrays," said Snyder-Mackler.His lab focuses on studies that allow him to probe questions central to human health, aging and evolutionary biology, often using companion animals or field animal research.

Next up is another huge citizen science canine effort now underway called the Dog Aging Project, where, according to Snyder-Mackler, "We are trying to understand what makes dogs tick (and age). Our lab uses molecular tools to try and identify how age and the environment interact to alter the dog immune system.So this new study has provided a really powerful roadmap to carrying out future studies in larger cohorts, which Dr. Karlsson is leading as part of the Dog Aging Project."

The project promises to explore what exactly are "dog years," other than the conventional wisdom of one dog year equal to about seven human years. What is known is that big dogs typically age more rapidly, an estimated 10 times faster than humans. By contrast, little dogs have a longer life span and can often live up to 20 years old.

Given that dogs share the human environment and have a sophisticated health care system but are much shorter-lived than people, they offer a unique opportunity to identify the genetic, environmental and lifestyle factors associated with healthy life span.

Snyder-Mackler and collaborators outlined the goals of their efforts in a recent Nature paper. The Dog Aging Project is an interdisciplinary, open-data, community science project that consists of a team of more than 100 staff, students, faculty and veterinarians from more than 20 academic institutions, along with over 30,000 canine participants and their owners.

The study investigators also include Kate E. Creevy, Joshua M. Akey, Matt Kaeberlein and Daniel E. L. Promislow, and afford great opportunities for Snyder-Mackler lab ASU graduate students, such as Brianah Mccoy and Layla Brassington, who are helping to lead efforts to better understand the role of the environment, diet, drugs and the epigenome on dog aging.

"I wanted to work at the interface of the public and academic science, and the Dog Aging Project is a great way to do that. So I hopped on the project," said Mccoy, who is a nontraditional student and among the first ASU Online students to pursue a PhD, having spent some time at the National Institute of Aging and Harvard Medical School prior to joining the Snyder-Mackler lab. Mccoy is particularly interested in diet and longevity, and is studying asubset of participating dogs that will be selected to be part of a new clinical study to explore the potential of the drug rapamycin to improve health.

Brassington is a master's degree student now in the molecular and cellular biology program at ASU who hopes to graduate in winter 2022.

"I read about the Dog Aging Project, and I was super excited to find a project that looked at health-related changes due to the environment," she said. She will be examining the environmental air quality and pollution levels of ozone, carbon monoxide and others nationwide.

Both are now working hard with the citizen science effort, generating experiments, and hope to publish their first data from the Dog Aging Project later this year.

The Dog Aging Project is actively looking for more participants. If you are a dog owner wanting to get involved, you can learn more at dogagingproject.org.

Written by JimFessenden,UMass Chan Medical School Communications, with contributions from Joe Caspermeyer, ASU.

Top photo: Kristoff, one of Sparky's Service Dogs, keeps watch at the feet of his handler Taylor Randle on Hayden Lawn on Sept. 8, 2016, as they hang out with other puppies being trained by students. Photo by Charlie Leight/ASU News

Go here to read the rest:
Dog study shows there's a lot more to behavior than just breed - ASU News Now

Posted in Molecular Genetics | Comments Off on Dog study shows there’s a lot more to behavior than just breed – ASU News Now

Page 446«..1020..445446447448..460470..»